Tanshinone IIA Ameliorates Non-Alcoholic Fatty Liver Disease Through Targeting Peroxisome Proliferator-Activated Receptor Gamma and Toll-Like Receptor 4

Journal of International Medical Research - United Kingdom
doi 10.1177/0300060519859750
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Nuclear Receptor Research
2017English

Peroxisome Proliferator-Activated Receptor Gamma Agonists in Renal Disease

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2006English

Peroxisome Proliferator-Activated Receptor

English

Peroxisome Proliferator Activated Receptor

English

Peroxisome Proliferator-Activated Receptor- Ameliorates Pulmonary Arterial Hypertension by Inhibiting 5-Hydroxytryptamine 2B Receptor

Hypertension
Internal Medicine
2012English

Peroxisome Proliferator-Activated Receptors Associated With Nonalcoholic Fatty Liver Disease

PPAR Research
Drug DiscoveryPharmacology
2017English

Peroxisome Proliferator-Activated Receptor (PPAR) Gamma in Cardiovascular Disorders and Cardiovascular Surgery

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Fatty Acids and Retinoids Control Lipid Metabolism Through Activation of Peroxisome Proliferator-Activated Receptor-Retinoid X Receptor Heterodimers.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

A Peroxisome Proliferator-Activated Receptor-Gamma Agonist and Other Constituents fromChromolaena Odorata

Planta Medica
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy